🧾 What This Document Is

This is a 6-K filing from Charming Medical Ltd. It's a current report used by foreign companies listed on U.S. exchanges to share important news with investors. Attached is the official offer letter that brings a new independent director onto the company's board. Think of it as the formal, public announcement of a key leadership appointment.

🏢 What The Company Does

👉 In simple terms, Charming Medical Ltd is a company incorporated in the British Virgin Islands with operations based in Hong Kong. Based on its name and location, it is likely involved in the medical device, healthcare product, or related technology sector. This filing shows it's taking steps to strengthen its corporate governance.

🎯 The New Director's Role

The company has hired Mr. Matthew Mo Kan Tsui as an Independent Director. His appointment is effective immediately. This isn't just a figurehead role; he has specific, important jobs:

• Chairman of the Audit Committee (oversees financial reporting and controls).
• Member of the Compensation Committee (helps set executive pay).
• Member of the Nominating Committee (helps find and recommend new board members).

👉 Why it matters: These are critical committees for any public company. Having a dedicated, independent person in charge of the Audit Committee is a major signal to investors about the company's commitment to financial transparency and proper oversight.

💰 Compensation & Terms

Mr. Tsui will be paid HK$384,000 per year (Hong Kong Dollars). This is roughly equivalent to US$49,000 at current exchange rates. The pay is issued monthly after he completes each service period. He will also be reimbursed for reasonable expenses, like travel for in-person board meetings.

His term is ongoing but is subject to re-appointment every year by the board. He is free to work for other companies while serving on Charming Medical's board.

🛡️ Legal Protections & Obligations

The agreement includes standard but important legal clauses for both sides:

• Confidentiality: Mr. Tsui agrees to protect the company's trade secrets and confidential business information.
• Indemnification: The company promises to legally protect and cover his legal costs if he is sued for actions taken in his role as director, unless it's due to gross negligence or willful misconduct.
• Director's & Officer's (D&O) Insurance: The company will add him to its insurance policy if one exists, which is a key protection for board members.
• Dispute Resolution: Any legal disputes will be handled through arbitration in New York, not a public court trial.

⚖️ Big Picture

👍 Strengths / Positives:

• Formalizes Governance: Bringing on a dedicated independent director for the Audit Committee improves structure and oversight.
• Clear Terms: The agreement clearly defines roles, pay, and protections, which is professional and reduces future ambiguity.
• Risk Protection: The inclusion of D&O insurance and indemnification helps attract qualified candidates by mitigating personal risk.

⚠️ Risks / Considerations:

• Company Stage: The annual compensation in HKD suggests the company may be operating on a smaller scale or is in an early growth phase.
• Dependence on Key Personnel: As a smaller company, the effectiveness of its board committees will heavily rely on the expertise and commitment of individuals like Mr. Tsui.
• Standard Boilerplate: Many clauses (like confidentiality and arbitration) are standard, offering routine rather than unique protections.

🔮 What's Next

With this appointment, Charming Medical's board and its key committees (Audit, Compensation, Nominating) are now formally staffed. Investors will look to see how this strengthened governance structure translates into action—such as more rigorous financial oversight or strategic planning—in the company's upcoming quarterly and annual reports.

🧠 The Analogy

This filing is like a sports team publicly announcing the signing of a new, seasoned coach for a critical unit (like the defense). The contract spells out the coach's salary, specific duties (calling defensive plays), and promises that the team will support them if they face criticism for their decisions. It signals the team is serious about improving that part of its game, but the real test will be how the team performs in the next season.

📇 Key Contacts & People

• Matthew Mo Kan Tsui – New Independent Director, Chairman of the Audit Committee. (Signature on agreement; contact details section left blank in the exhibit)
• Kit Wong – Chairman of the Board, signed the offer letter on behalf of Charming Medical Limited.
• Company Address: Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong

🧩 Final Takeaway

This is a routine but important corporate governance filing. Charming Medical Ltd. has formally appointed an independent director to chair its Audit Committee, a move designed to bolster investor confidence in its financial oversight. The key terms are standard, and the real impact will depend on the company's future actions and financial performance.